Brief: Apexigen Inc Files For Primary Offering Of 3.7 Million Shares Of Common Stock Issuable Upon Exercise Of Warrants - SEC Filing
12/08/2022 22:48
Aug 12 (Reuters) - Apexigen Inc APGN.O :
* APEXIGEN INC FILES FOR PRIMARY OFFERING OF 3.7 MILLION
SHARES OF
COMMON STOCK ISSUABLE UPON EXERCISE OF WARRANTS - SEC FILING
* APEXIGEN INC FILES FOR SECONDARY OFFERING OF 14.4 MILLION
SHARES
OF COMMON STOCK, 849,500 WARRANTS TO PURCHASE SHARES OF COMMON
STOCK
Further company coverage: APGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apexigen
See all newsBrief: Apexigen Inc - On August 15, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
Brief: Apexigen Says Phase 2 Data Evaluating Sotigalimab, Its CD40 Agonist Antibody, In Combination With Doxorubicin Marked Increases In Overall Survival Observed Across Soft Tissue Sarcoma Patients
Apexigen rises on buyout deal with Pyxis Oncology
Brief: Pyxis Oncology To Acquire Apexigen For Total Enterprise Value Of About $16 Million
Brief: Apexigen Inc Says On April 11, Co Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq